Candid Health, which automates medical billing and claims processes, completes $120 million Series D financing led by Sixth Street Growth

Candid Health's path is typical: first productizing the most painful billing, claims, and collections processes for medical institutions, then handing over labor-intensive edge processes to automated systems. Public materials show the company emphasizes itself as an "autonomous RCM platform" and plans to use the new funding to expand its automation tools and AI agent capabilities. In terms of capital, what makes such companies valuable is not whether they can do AI, but whether they can directly enter the cash flow chain. Once medical revenue cycle management is integrated, the platform becomes more than just software; it embeds itself in the settlement friction layer between hospitals, insurers, and payments, effectively gaining a piece of the enterprise financial operating system. Historically, similar high-valuation logic is common among SaaS companies that first penetrate the backend and then expand to core processes: initially selling efficiency, then selling control. Candid's valuation this time is said to have tripled compared to its Series C in 2025, indicating that the market no longer sees it merely as a billing tool, but is pricing the imagination of "AI agents taking over the backend." Essentially, it belongs to technology substitution: the claims and billing work that previously required a lot of manual processing is being consumed by agent-based software; whoever can automate backend processes deeply enough can extract some profit from labor costs. ABAB News · Cognitive Laws 1. The most valuable AI is not the one that can chat, but the one that can collect money. 2. The more complex the process, the more expensive the automation. 3. First eat the backend, then take pricing power.